XTAI
1711
Market cap730mUSD
Jul 09, Last price
42.80TWD
1D
-0.93%
1Q
10.59%
Jan 2017
112.41%
Name
Everlight Chemical Industrial Corp
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Everlight Chemical Industrial Corporation, founded in Taipei, Taiwan, in 1972, operates as a global producer and distributor of a diverse array of chemical products. Its extensive market reach spans Taiwan, the broader Asian region, the United States, Europe, and other international territories. The company's product portfolio encompasses a comprehensive range of dyes, including those for textiles, leather, inkjet printing, metals, paper, and advanced functional chemicals for fabric applications, digital textile solutions, and solar-sensitized dyes. Furthermore, Everlight provides specialized chemical additives such as light stabilizers, crucial for enhancing the durability of weather-resistant coatings and plastics, alongside anti-yellowing agents for polyurethane and thermoplastic polyurethane materials, and essential raw materials for sunscreen cosmetic formulations. In the pharmaceutical sector, it develops and manufactures active pharmaceutical ingredients (APIs), notably prostaglandin APIs, as well as APIs for treating cardiovascular conditions and Parkinson's disease. For the electronics industry, the corporation supplies high-performance materials like photoresists, developers, polishing solutions, and sophisticated functional surface nano-coatings designed for integrated circuits (ICs), liquid crystal displays (LCDs), light-emitting diodes (LEDs), and touch panel (TP) applications. Additionally, it produces and markets imaging consumables, including toner and cartridges, compatible with laser printers, photocopiers, and fax machines. Beyond manufacturing, the company actively engages in the trading of chemical products and raw materials, offers expert technical consulting services, and produces pigments, toners, and specialized chemicals for electronic applications.
Valuation
Title TWD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||